Inactive

AMENDMENT 1 to FDA-RFP-1223623 (Support for the Establishment and Operation of a Center of Excellence for Engagement with Compounding Outsourcing Facilities) The purpose of Amendment 1 to FDA-RFP-1223... AMENDMENT 1 to FDA-RFP-1223623 (Support for the Establishment and Operation of a Center of Excellence for Engagement with Compounding Outsourcing Facilities) The purpose of Amendment 1 to FDA-RFP-1223623 is to post FDA responses to timely vendor questions received for this solicitation. Amendment 1 includes an "FDA Responses to Vendor Questions" document, an Amendment 1 revision to the solicitation document and an Amendment 1 revision to the Statement of Work. All revised documents are attached and changes are highlighted in yellow throughout the documents. Please refer to the solicitation Amendment 1 documents for further information.